Sign in

Shweta Shah

@nefron1310.bsky.social
905 followers 879 following 35 posts

Peds Nephrologist #NephSky

PostsRepliesMedia
Reposted by Shweta Shah
American Kidney Fund @kidneyfund.bsky.social · 14/04/2026
BREAKING: The FDA has approved Travere Therapeutics Filspari (sparsentan) to treat adults and children ages 8+ with focal segmental glomerulosclerosis (FSGS), reducing proteinuria. As the first and only FDA-approved treatment for #FSGS, it offers new hope for patients: bit.ly/481S6iA
011
Reposted by Shweta Shah
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 02/04/2026
The #Effluent8 of #NephMadness are live! ajkdblog.org/2026/04/02/n... Dogs 🐶win? That seems like a #BlueRibbonFail 😏 The rest seem solid choices IMO!
ajkdblog.org
#NephMadness 2026: The Effluent Eight
It’s time for our first step on the road to naming a Champion, announcing the winners of each of this year’s regions! Is your The mighty Blue Ribbon Panel has conferred, and the picks a…
042
Shweta Shah @nefron1310.bsky.social · 18/03/2026
#NephMadness party was a huge success! Awesome presentations by both peds and IM team! @nephmadness.bsky.social
034
Shweta Shah @nefron1310.bsky.social · 14/03/2026
This year we are hosting a combined Med-Peds Nephrology. Yay!! Finally getting together #NephMadness party! Kidney Heroes Of Houston! We are comically neon!!! @nephmadness.bsky.social
031
Shweta Shah @nefron1310.bsky.social · 05/12/2025
Something has to change! We need more of us! #NephSky @nefronica-2rair.bsky.social @aspneph.bsky.social @rheaultm.bsky.social @akcanarikan.bsky.social @jostflynnmd.bsky.social @sugarkro.bsky.social @drm-sudha.bsky.social @and
021
Reposted by Shweta Shah
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 25/11/2025
An announcement www.nephjc.com/news/2025/11... #NephJC @kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social
nephjc.com
Taking the reigns — NephJC
In April 2014, Swapnil and I launched NephJC—and within weeks we were overwhelmed by the sheer work of running a twice-monthly, Twitter-based journal club. Fortunately, we also had a deep bench of fri...
85415
Reposted by Shweta Shah
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 19/11/2025
These are not FDA approved yet - this trial + VISIONARY for Sibeprenlimab will lead to approval soon Approved = Nefecon Atrasentan Sparsentan Iptacopan (I think) #Nephjc
493
Reposted by Shweta Shah
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 19/11/2025
Excellent comparison of completed IgAN studies from today's @CSNSCN webinar from Kevin Yau #NephSky
172
Reposted by Shweta Shah
Michelle Rheault, MD @rheaultm.bsky.social · 08/11/2025
Late breakers that included children: ✅Setanaxib in Alport (12+) Late breakers that did NOT include children: 🚫Atacicept in IgAN 🚫CONFIDENCE 🚫PISCES: Fish oil in Dialysis 🚫LIBERATE-D 🚫balcinrenone + dapa 🚫Obintuzumab in lupus nephritis 🚫Sibeprenlimab in IgA 🚫MIL62 in membranous +more #KidneyWk
12012
Shweta Shah @nefron1310.bsky.social · 05/11/2025
Peds nephrons at #ASN2025 #KidneyWk , participate in @aspneph.bsky.social scavenger hunt and win prizes! Download ASPNGo App!! @nefronica-2rair.bsky.social @coleaugust.bsky.social
000
Reposted by Shweta Shah
Nephrology Journal Club @nephjc.bsky.social · 29/10/2025
Clinical importance of prediction tools: 🔬 The prediction tool was developed with the data from 4000 people in multinational and multiracial cohorts and can be generalized to all. Do you routinely use prediction tools with IgAN patients? #NephJC
142
Reposted by Shweta Shah
Nephrology Journal Club @nephjc.bsky.social · 29/10/2025
Treatment in children: 👶💉 Management is based on RAS blockade, salt restriction, and blood pressure control. Glucocorticoids are used in those with persistent proteinuria or high-risk features, sometimes combined with cyclophosphamide in severe cases. #NephJC
195
Reposted by Shweta Shah
Nephrology Journal Club @nephjc.bsky.social · 06/09/2025
🤔 How often is end-stage kidney disease in patients with MCD/ FSGS? #NephSky #MedSky @brianrifkin.bsky.social dissected the conclusions from the RaDar study in this #NephJCshorts *the original article from @asnpublications.bsky.social www.nephjc.com/news/nephjc-...
nephjc.com
NephJC Shorts: MCD and FSGS Outcomes — NephJC
A NephJC Shorts discussion of the long term data on kidney failure in FSGS and MCD
288
Reposted by Shweta Shah
Nephrology Journal Club @nephjc.bsky.social · 23/07/2025
Everything said and done - although eGFR diff may signal ominous outcomes - practically speaking following one eGFR over time and seeing the eGFR fall predicts outcomes better than anything else ! And that’s what would be feasible across economies ! #NephJC
083
Reposted by Shweta Shah
Nephrology Journal Club @nephjc.bsky.social · 02/07/2025
The #NephJC editorial team knows that plenty of papers deserve attention between our bi-monthly, full-length discussions ✨Enter #NephJCShorts - quick hits with a critical eye 🦅 on high-impact reads www.nephjc.com/news/nephjc-... #MedSky #NephSky
nephjc.com
Introducing NephJC Shorts — NephJC
In just over a decade of critical appraisal on NephJC, we have done several experiments. Some of them have worked out phenomenally well, such as the Freely Filtered podcast. Others were not ready for ...
01110
Reposted by Shweta Shah
Michelle Rheault, MD @rheaultm.bsky.social · 22/06/2025
From Rivka Galchen’s article in @newyorker.com: “The kidney, a tremendously under-celebrated organ, basically does four-dimensional sudoku with ions.” And that’s how I’m going to explain it from now on.
“The kidney, a tremendously under-celebrated organ, basically does four-dimensional sudoku with ions.”
1369
Reposted by Shweta Shah
Michelle Rheault, MD @rheaultm.bsky.social · 11/06/2025
I do the same with any agent. Treat for 2 years then try off. If relapse, then another 2 years. #NephJc I don’t think there’s great data. Just seems a good balance of risk.
194
Reposted by Shweta Shah
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 03/06/2025
Congrats to all the @asnkidney.bsky.social lifetime and mid-career awardees! @ksusztak.bsky.social @genetickidneydoc.bsky.social @shinamenon.bsky.social @michellejtx.bsky.social and everyone else!
award winner list
4317
Shweta Shah @nefron1310.bsky.social · 14/05/2025
DDAvP will increase VWF levels but in an uremic mileu does it really help towards platelets adhesion? #NephJC
021
Shweta Shah @nefron1310.bsky.social · 14/05/2025
Would make sense to check VWF otherwise hard to prove anything unless they compare with their previous institutional cohort # NephJC
130
Reposted by Shweta Shah
Nephrology Journal Club @nephjc.bsky.social · 14/05/2025
T0c So how does DDAVP skip the bleeding drama? 🩸 🧬 Desmopressin → triggers cAMP → exocytosis of vWF & FVIII from endothelium ➡️ Boosts platelet adhesion in uremic dysfunction ⏱️ Onset: 30–90 min ⏳ Duration: 4–8 h #NephJC
0103
Shweta Shah @nefron1310.bsky.social · 14/05/2025
We used to do pre procedure DDAVP for abnormal PFA’s, mostly in CKD/ uremic kids # NephJC
100
Shweta Shah @nefron1310.bsky.social · 14/05/2025
Peds Nephrologist @texaschildrens.bsky.social No COI #NephJC
nephjc.bsky.social
Nephrology Journal Club (@nephjc.bsky.social)
A twice monthly nephrology journal club that used to meet on Twitter. Hashtag #NephJC www.nephjc.com
340
Reposted by Shweta Shah
aspneph.bsky.social @aspneph.bsky.social · 02/05/2025
Join hosts Emily Zangla and Jordy Salcedo with moderators from four nephrology sessions at the 2025 Pediatric Academic Societies Conference in Honolulu, Hawaii. buff.ly/HdQWefG
011
Shweta Shah @nefron1310.bsky.social · 30/04/2025
Anyone seen membranous nephropathy( PLA2r neg) in pt with long standing Thal major, transfusion dependent? #NephSky #askrenal @askrenal.bsky.social
000
Reposted by Shweta Shah
aspneph.bsky.social @aspneph.bsky.social · 22/04/2025
🚨 The ASPN Scavenger Hunt is almost here! 🗓 Launches April 25 – are you ready? ✅ Download the ASPN Go App now Complete tasks ➡ Win prizes! 🎁 Daily Yeti Cups + a grand prize Amazon Gift Card #ASPNHunt #ComingSoon buff.ly/br6ocqR
021
Shweta Shah @nefron1310.bsky.social · 22/04/2025
Attending #PAS2025 ? Fun way to engage with fellow nephrons through our ASPN Go App!!📱📲 #pedsneph #ASPNHunt @aspnr.bsky.social @nefronica-2rair.bsky.social @drm-sudha.bsky.social @sugarkro.bsky.social @asouth-neph.bsky.social
012
Reposted by Shweta Shah
Joel Topf @kidneyboy.bsky.social · 25/03/2025
Skeleton Key Group still going strong with their 37th electrolyte case www.renalfellow.org/2025/03/19/s...
renalfellow.org
Skeleton Key Group Case #37: A case of elevated anion gap metabolic acidosis
Welcome to the 37th case of the Skeleton Key Group, a team of nephrologists from around the world who build a periodic education package for the Renal Fellow Ne
0176
Shweta Shah @nefron1310.bsky.social · 25/03/2025
#NephMadness party ✅ Were there cookies? ❌ Was it a great discussion? ✅✅ Some were resistant, some needed incremental push, lot of disasters and conflicts, but finally convinced!!🤣🤣🤣 @nephmadness.bsky.social Genetics in FSGS 🏆
064
Shweta Shah @nefron1310.bsky.social · 25/03/2025
After listening to this podcast, i might be a convert now! Genetic counseling might be more important than sending genetic testing!! @nephmadness.bsky.social #NephMadness
022
Shweta Shah @nefron1310.bsky.social · 25/03/2025
Love the science behind anti-nephrin Ab but 35% AA have one risk allele for APOL-1 & 14% have 2 risk alleles! Those r huge number of people predisposed to AMKD! IMO, it will be the winner , it has to🤣 @nephmadness.bsky.social
010
Reposted by Shweta Shah
Michelle Rheault, MD @rheaultm.bsky.social · 24/03/2025
Are you a patient with Alport syndrome? The 2025 In-Person Alport Connect meeting will be in Chicago on July 19-20th. Child and teen programming available. See you there! alportsyndrome.org/for-patients...
075
Shweta Shah @nefron1310.bsky.social · 21/03/2025
On it! @nephmadness.bsky.social party Tuesday! Reading in process!! #NephMadness #NephSky
031
Shweta Shah @nefron1310.bsky.social · 04/03/2025
APOL1 versus Anti-nephrin!! Loving it #NephMadness
062
Shweta Shah @nefron1310.bsky.social · 04/03/2025
So excited for this topic!! #NephMadness 2025
142
Reposted by Shweta Shah
American Journal of Kidney Diseases @ajkd.bsky.social · 01/03/2025
Happy #NephMadness Day! The 8 regions of #NephMadness 2025 have been revealed on the #AJKDBlog. If you're a #NephMadnessNewbie, we explain everything here: buff.ly/DCZDRfN Looking forward to the fun and learning with all of you!
buff.ly
Welcome to #NephMadness 2025
Here it is, the 13th edition of NephMadness!  Whether you’re new to the competition or just want to relive past glories, we have all the info you need for NephMadness 2025: What is NephMadnes…
02618
Reposted by Shweta Shah
Tom Forbes @kidneytom.bsky.social · 20/02/2025
@louiseoni.bsky.social on Lupus Nephritis to close out this amazing session. #IPNA2025 Glom Dis update.
154
Reposted by Shweta Shah
Michelle Rheault, MD @rheaultm.bsky.social · 19/02/2025
Dr Hugh McCarthy: What if we did genetic testing on all children with ESKD? Chinese study shows hit rate of 46.7% #IPNA2025 pubmed.ncbi.nlm.nih.gov/39363361/
1156
Reposted by Shweta Shah
Michelle Rheault, MD @rheaultm.bsky.social · 21/02/2025
Dr Julien Hogan presents results of RCT in children with FR nephrotic syndrome treated with Rituximab +/- IVIG. Result: Addition of IVIG showed no benefit on relapse free survival. #IPNA2025
1166
Shweta Shah @nefron1310.bsky.social · 20/02/2025
Can’t even!! ☀️🌞🌻❄️☃️
010
Shweta Shah @nefron1310.bsky.social · 12/02/2025
Was great to be back! #NephJC after 40 min, figured out deck.blue :-)) Thanks @verner-venegas.bsky.social
050
Reposted by Shweta Shah
Nephrology Journal Club @nephjc.bsky.social · 12/02/2025
The current study brings to light that aldosterone production, independent of renin and AG II, is a continuum with potentially many people below the threshold of the classic phenotypic findings seen in primary aldosteronism. #NephJC
182
Reposted by Shweta Shah
Melvin Chan @mchanmd.bsky.social · 12/02/2025
Similar to SPRINT/ESPRIT/BPROAD, in peds nephrology we may target lower than normotension (ie less than 95%tile). In one using CkID dataset there was a differentiation between glomerular vs nonglomerular #NephJC www.ahajournals.org/doi/10.1161/...
ahajournals.org
American Heart Association Journals
061
Shweta Shah @nefron1310.bsky.social · 12/02/2025
Shweta Shah, Peds nephrologist at Texas Children’s Houston. No COI, except that I have been MIA for a while 😔😔 #NephJC
350
Shweta Shah @nefron1310.bsky.social · 31/01/2025
www.kireportscommunity.org/post/unlocki... @ghobby.bsky.social @kireports.bsky.social
kireportscommunity.org
Unlocking the Role of Complement: The Evolution of C3G and Immune Complex MPGN Classification
Written by : Gerren Hobby, MDWe will be discussing complement-mediated glomerulonephritis in this blog post. This has been an exciting topic to watch over the past several years as we have come to a b...
052
Reposted by Shweta Shah
American Journal of Kidney Diseases @ajkd.bsky.social · 28/01/2025
Patient and Healthcare Provider Perspectives on Showering for Patients With Hemodialysis Central Venous Catheters: A Survey Study bit.ly/3BV51WQ #OpenAccess
043
Shweta Shah @nefron1310.bsky.social · 21/01/2025
Why should it always be snow MAN!! 🤣 #Houstonsnow #coldweather ☃️⛄️❄️🌹
000
Shweta Shah @nefron1310.bsky.social · 14/01/2025
Throwback to med school days! Enjoying reading through my favorite Guyton textbook of physiology.
030
Shweta Shah @nefron1310.bsky.social · 29/12/2024
Had a lovely 12 hr vacation @Houston airport, walked around 3 terminals, changed gates 4x and now returning home only to do it again tomorrow!! #wintertravels #holidaytravels #torontoherewecome
media.tenor.com
a group of people are walking through an airport with a sign that says lg
ALT: a group of people are walking through an airport with a sign that says lg
010
Shweta Shah @nefron1310.bsky.social · 04/12/2024
We are excited to welcome our new incoming fellows 🤗🤗Dr. Olubunmi “Bunmi” Fatoki and Dr. Joshua Lipsitz to our renal family here at Texas Children’s -Baylor College of Medicine!! 🥳 A big congratulations to all those who matched into the peds neph community! 🥰❤️🫘 #nephsky #matchday #pedsneph
060